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This study was designed to determine whether N-acetylcysteine (NAC, C5H9–NO3S), a compound from Allium species may be
used as a complementary therapeutic agent, to inhibit high-sucrose induced-obesity and its eﬀects on glucose tolerance, in vivo
low-density lipoprotein (LDL)-oxidation and serum oxidative stress in rats. Initially, 24 male Wistar rats were divided into two
groups: controls receiving standard chow (C, n = 6) and those receiving high-sucrose diet (HS, n = 18). After 22 days, (HS)
group was divided into three groups (n = 6/group); (HS-HS) continued to eat high-sucrose diet and water; (HS-N) continued
to eat high-sucrose diet and received 2 mg l−1-NAC in its drinking water; (HS-CN) changing high-sucrose to standard chow and
receiving 2 mg l1-NAC in its drinking water. After 22 days of the HS-group division (44 days of experimental period) body weight,
body mass index and surface area were enhanced in HS-HS rats (P < .001). HS-HS rats had glucose intolerance, increased serum
triacylglycerol (TG), very low-density lipoprotein (VLDL), oxidized-LDL (ox-LDL) and lipid-hydroperoxide (LH) than the others
(P < .01). NAC in HS-N and HS-CN rats reduced the obesity markers, feed eﬃciency, LH and ox-LDL, as well normalized glucose
response, TG and VLDL (P < .01) in these groups compared with HS-HS. Total antioxidant substances, GSH/GSSG ratio and
glutathione-reductase, were higher in HS-N than in HS-HS (P < .01). In conclusion, NAC improved high-sucrose diet-induced
obesity and its eﬀects on glucose tolerance, lipid proﬁle, in vivo LDL-oxidation and serum oxidative stress, enhancing antioxidant
defences. The application of this agent may be feasible and beneﬁcial for high-sucrose diet-induced obesity, which certainly would
bring new insights on obesity-related adverse eﬀects control.
1.Introduction
The use of plant compounds in managing of pathology has
increased in recent years, as adjunct therapy and alternative
medicine. In view of the fact that reactive oxygen substances
(ROS) are implicated in the etiology of many degenerative
diseases; antioxidants have become one among the most
important topics in nutrition.
N-Acetylcysteine (NAC, C5H9–NO3S), an organosulfur
from Allium plant, due to its potential antioxidant activity
has been considered responsible, at least in part, for onion
and garlic beneﬁcial eﬀects in warding oﬀ illnesses and
cardiovascular protection [1, 2]. It is a thiol agent whose
biological importance has crossed the boundaries of botany,
pharmacognosy and natural products [3, 4]. NAC has been
successfully used as adjunct therapy in various pulmonary
disorders [5], to improve hepatic function [6], to reduce
metal toxicity [7], but the mechanisms responsible for these
activities are not yet completely understood.
R e c e n t l y ,w eh a v er e p o r t e dt h ep r e v e n t i v ee ﬀects of NAC
on dyslipidemic proﬁle and alleviation of hyperglycemia in
rats given standard chow and 30% sucrose in its drinking
water [8]. It was also demonstrated NAC beneﬁcial eﬀects
on sucrose-induced insulin resistance and oxidative stress [9,
10]. However, its eﬀect on obesity-related metabolic changes
duehigh-sucroseintake,asafoodcompoundisnotpresently
known. An increasingly preference for reﬁned foods and diet
containing high levels of sucrose has resulted in a drastic
increase in the incidence of obesity. Dietary sucrose is an
importantmodulatoroftheobesity-relateddiseases[11],but2 Evidence-Based Complementary and Alternative Medicine
whether dietary NAC can reverse these adverse eﬀects merits
to be investigated.
It is well accepted that obesity exerts deleterious eﬀects
on health due the remarkable abilities to induce oxidative
stress, an imbalance between oxidants and antioxidants
systems in favor of the former. During energy metabolism,
the mitochondrial respiratory chain represents a major
intracellular source of ROS. As the use of oxygen is vital for
oxidative phosphorylation, alterations in food constituents
or fuel for energy generation may result in higher ROS
production, thus inducing oxidative stress [12].
Moreover,oxidativemodiﬁcationoflow-densitylipopro-
tein (LDL) producing oxidized-LDL (ox-LDL) is the key
step in the sequence of events leading to atherosclerosis.
Researches on NAC actions have been reported in a scattered
fashion [9, 13–15], but its eﬀects on lipid proﬁle and
in vivo ox-LDL had drawn little attention until recently.
Since the majority of metabolic changes related to oxidative
stress and obesity, remain clinically silent and only become
manifest when health damage is eﬀectively installed, studies
to discover the relative potency of NAC on LDL-oxidation in
vivo may have particular importance.
Thus, the major purpose of the present study was to
examine whether dietary N-acetylcysteine (NAC) supple-
mentation may improve high-sucrose diet-induced obesity
and its eﬀects on glucose tolerance, lipid proﬁle, in vivo LDL-
oxidation and serum oxidative stress.
2. Methods
2.1. Animals. All experiments and procedures were per-
formed in accordance with the Guide for the Care and Use of
Laboratory Animals published by the US National Institute
of Health, and approved by the Ethics Committee of The
Institute of Biosciences, S˜ ao Paulo State University, UNESP,
Brazil. Male Wistar 24 rats, 60 days of age, weighing 202.8
± 5.0g were individually housed in polypropylene cages
in an environmentally controlled, clean-air room with a
temperature of 22 ± 3◦C, 12h light:dark cycle, and a relative
humidity of 60 ± 5%.
2.2. Obesity Induction and Experimental Design. Initially
the animals were randomly divided into two groups. A
control (C, n = 6) group received standard rodent chow
(BioBase, S˜ ao Paulo, Brazil), containing 23.54% protein,
43.88% carbohydrate (40.75% starch and 3.13% sucrose),
1.87% fat, 13.85% ﬁber (by weight) and 2.86kcalg−1 of
metabolizable energy. The (HS, n = 18) group received
high-sucrose diet containing (by weight) 23.60% protein,
49.85% carbohydrate (24.5% starch and 27.35% sucrose),
3.27% fat, 9.39% ﬁber and 3.23kcalg−1 of metabolizable
energy. Food intake and drinking solutions consumption
were evaluated daily at the same time (9:00-10:00h), as the
diﬀerence between food and drinking solution given and the
leftover. The body weights were determined once a week.
The high-sucrose diet was obtained mixing 600 g sucrose
and 60g of soy oil to 1000g of a previously triturated
standard chow. Casein was added to achieve the same
proteincontentasthestandardchow.Thedietaryingredients
were homogenized in 60◦C warm distilled water and the
homogenate was used to prepare the pellets. Therefore, both
control and experimental diets were given fresh each day as
dry pellets, and there was no spillage. The proportions of
dietary protein, carbohydrate and fat were determined by
direct analysis [16].
After 22 days of dietary treatments, the animals were
anaesthetized (0.1ml ip of 1% sodium barbiturate) for the
measurement of body length (nose-to-anus, or nose-anal
length). The body weight and body length were used to
conﬁrm the obesity through the obesity parameters, body
mass index (BMI, g/cm2) = body weight/length2,s u r f a c ea r e
(g0.7) = body weight0.7 andtheLee-index (gcm1) = cuberoot
of body weight/length [17].
In order to more appropriately study the eﬀects of NAC
on high-sucrose diet-induced obesity, the (HS) group was
then randomly divided into three subgroups (n = 6/group):
(HS-HS) group, continued to eat high-sucrose diet and
received water; (HS-N) group continued to eat high-sucrose
diet and received NAC (2mgl−1) in its drinking water; (HS-
CN) group that changed high-sucrose diet to standard-chow
andreceived2mgl−1 NACinitsdrinkingwater.RatsintheC
group(n=6)remainedwithstandardchowandwaterduring
all experimental period. The HS-CN group was adopted to
evidence whether there is synergistic eﬀects between NAC
intake and changing high-sucrose diet to control chow, on
obesity adverse eﬀects. The dose of NAC used was equivalent
to 32.2–39.2mg/day in humans (70kg) and was calculated
from NAC concentration in onion (Allium cepa,4 5m gk g −1)
[2]. This dose corresponded to intake one onion/day in
humans [8]. The food intake and body weight were used
to determine the energy intake (EI, kcal/day) = (mean
food consumption per day × dietary metabolizable energy)
and feed eﬃciency (FE%) = (mean body weight gain ×
100/energy intake).
2.3. Oral Glucose Tolerance Test and Glycemic Response.
After 22 days of the (HS) group division (44 days of the
experimental period) all animals were fasted for 12–14h and
submitted to the oral glucose tolerance test (OGTT). So,
glucose was orally given (gastric tube) (2gkg−1), as a 20%
aqueous solution. Blood glucose levels were measured before
theglucoseadministrationandat30,60,90,120and150min
after the glucose loading. Blood was taken from a tail vein
andglucoseconcentrationsweredeterminedbyanautomatic
glucose analyser (Boehringer Mannheim, Eli Lilly Ltda, S˜ ao
Paulo, Brazil). The glycemic response was calculated from
the area under the glucose-response curve above the fasting
level [11], as a mean to estimate release insulin in response to
glucose[18].AftertheOGTT,theanimalswereanaesthetized
(0.1ml ip of 1% sodium barbiturate) for measurementof the
body length [17], and were sacriﬁced by decapitation.
2.4. Serum Determinations. Total blood was collected by
a funnel into a centrifuge tube and allowed to clot to
obtain the serum. Serum was separated by centrifugation at
1400g for 10min. Triacylglycerol (TG), total cholesterol andEvidence-Based Complementary and Alternative Medicine 3
Table 1: Eﬀect of NAC on parameters related to obesity induced in
male Wistar rats by high-sucrose diet.
Parameters Groups
CC o n t r o l
(standard fed)
HS Obese
(high-sucrose diet fed)
Initial body weight (g) 201.5 ± 5.2 202.0 ± 3.7
Final body weight (g) 295.1 ± 2.9 307.1 ± 2.8 a
Body weight gain (g) 93.6 ± 1.2 125.1 ± 1.7 a
Body mass index (g/cm2) 0.60 ± 0.03 0.66 ± 0.01 a
Surface area (g0.7) 53.6 ± 1.1 57.6 ± 0.6 a
Lee-index (g/cm) 0.30 ± 0.02 0.36 ± 0.01 a
Values are given as mean ± SD of the mean.
aValues signiﬁcantly diﬀerent from C group, P < .001.
high-density lipoprotein cholesterol (HDL)were determined
in serum by enzymatic method (test Kit CELM, Modern
Laboratory Equipment Company, S˜ ao Paulo, Brazil). Total
antioxidant substances (TAS), or total antioxidant capacity
of serum (Test Kit Randox Laboratories Ltd, Crumlin, Co.
Antrim, UK), total protein [19], LDL [20], ox-LDL [20, 21]
and lipid-hydroperoxide (LH) [21] were also determined in
serum.
The glutathione antioxidant system was assessed in
serum by glutathionereductase (GSH-reductase, E.C.1.6.4.2)
activity, oxidized glutathione (GSSG) and reduced glu-
tathione (GSH). GSH-reductase activity was evaluated mon-
itoringNADPH(reducednicotinamideadeninedinucleotide
phosphate) oxidation at 340nm [22]. The assay mixture
contained 1mM Tris buﬀe r ,p H8 . 0 ,5 m ME D T A ,3 3 m M
GSSG and 2mM NADPH. GSSG was assayed with 2mM
5,5 -dithiobis-(2-nitrobenzoic) acid (DTNB) in 50mM
KH2PO4. GSH was measured by a kinetic assay in reaction
medium containing 0.6mM DTNB, 0.2mM NADPH and
2U of glutathione reductase in 50mM KH2PO4 [23].
Enzyme activities were performed at 25◦C using a micro-
plate reader (µQuant-MQX 200, Kcjunior software, Bio-Tec
Instruments, Winooski, VT, USA). The spectrophotometric
determinations were performed in a Pharmacia Biotech
spectrophotometer with temperature-controlled cuvette
chamber (UV/visible Ultrospec 5000 with Swift II appli-
cations software to computer system control, 97 4213,
Cambridge, England, UK).
2.5. Statistical Analysis. Analysis of variance was used to
examine the treatment eﬀect and comparison between the
means was performed by Tukey’s test, with 0.05 as the
signiﬁcant level (SigmaStat software for windows, Jandel
Corporation, San Rafael, CA, USA).
3. Results
3.1. Obesity Markers. After 22 days of the experimental
period, the body weight, BMI, Lee-index and surface area
were higher in HS rats than in C (P < .001) (Table 1).
3.2. General Characteristics of Rats, Nutritional Parameters
and Glucose Response. Body weight gain and ﬁnal body
weight, feed eﬃciency, BMI and surface area were higher in
HS-HS rats than in the others. Food consumption, energy
intake and drinking solution ingested were lower in HS-HS,
HS-N and HS-CN groups than in C. HS-HS rats had the
highest FE. NAC normalized FE comparing HS-N and HS-
HSrats(P <.01).FEwasreducedinHS-CNratsascompared
with HS-HS (P < .01), but was enhanced comparing HS-
CN and C groups (P < .01). There were no signiﬁcant
diﬀerences in NAC intake between HS-N and HS-CN rats.
The glycemic response was higher in HS-HS rats than in the
others (Table 2).
T h ef a s t i n gb l o o dg l u c o s el e v e l sw e r ec o m p a r a b l ei na l l
four groups. The HS-HS rats had 60-min overload glycemia
in relation to the fasting condition. For C, HS-N and HS-
CN groups, the glucose level peaked at 30min, and dropped
thereafter. Glucose levels after OGTT were higher than the
respective fasting glucose levels in HS-HS rats. The glycemia
returned to the fasting levels at 150 min after the glucose
administration in HS-N and HS-CN rats (Figure 1).
3.3. Lipid Proﬁle and Oxidative Stress in Serum. Triacylglyc-
erol, VLDL, LDL, ox-LDL were signiﬁcantly higher, while
HDL and HDL/TG ratio were lower in HS-HS than in C
rats (P < .01). NAC normalized TG and VLDL, as well
reduced total cholesterol, LDL and ox-LDL, comparing HS-
N and HS-HS rats (P < .01). HDL/TG ratio was higher in
HS-N than in HS-HS rats (P < .01). The combination of
NACintakeanddietchangingfromhigh-sucrosetostandard
chow in HS-CN had no eﬀects on LDL concentration, but
normalized TG, cholesterol, HDL, VLDL and HDL/TG ratio.
Ox-LDL was lower (P < .01) in HS-CN than in HS-HS, but
there were no signiﬁcant changes in ox-LDL of HS-N and
HS-CN rats.
Analysing the oxidative stress markers, we can see that
LH, GSH-reductase were higher, while TAS and GSH/GSSG
ratio were signiﬁcantly lower in HS-HS than in C rats
(P < .01). LH was lower, while TAS, GSH-reductase and
GSH/GSSG ratio were higher in HS-N than in HS-HS and
C rats. There were no signiﬁcant diﬀerences in LH and GSH-
reductase comparing HS-CN with C. TAS and GSH/GSSG
ratio were higher in HS-CN than in C and HS-N groups
(Table 3).
4. Discussion
Taking into account the association of oxidative stress and
various pathological conditions, much attention is being
paidondietaryantioxidantsasalternativetherapeuticagents.
To the best of our knowledge this is the ﬁrst study that
evaluated the NAC eﬀects on oxidative stress, lipid proﬁle
and serum in vivo ox-LDL in rats previously submitted to
experimental obesity duehigh-sucrosechowintake. Recently
we have reported the beneﬁcial eﬀects of NAC in rats
receiving both NAC and 30% sucrose in its drinking water
for 30 days. In the present study, NAC was given to obese rats
to ﬁnd out whether NAC intake could reduce the obesity-
adverse eﬀects. The rate of obesity in general population has4 Evidence-Based Complementary and Alternative Medicine
Table 2: General characteristics, nutritional parameters and glycemic response of the rats.
Determinations Groups
C HS-HS HS-N HS-CN
Initial body weight (g) 295.1 ± 7.5 301.5 ± 6.5 307.6 ± 6.3 304.6 ± 2.5
Final body weight (g) 388.7 ± 2.7 b 446.4 ± 3.6 a,c,d 403.7 ± 6.2 b 407.5 ± 8.6 b
Body weigh gain (g) 93.6 ± 3.5 b 119.3 ± 3.2 a,c,d 77.1 ± 14.3 b 81.9 ± 11.6 b
Food consumption (g/day) 28.04 ± 6.07 b,c,d 21.29 ± 1.87 a 18.76 ± 2.91 a 21.11 ± 2.12 a
Body mass index (g/cm2)0 . 6 0 ± 0.02 b 0.71 ± 0.01 a,c,d 0.64 ± 0.03 b 0.65 ± 0.03 b
Surface area (g0.7) 64.9 ± 2.3 b 71.6 ± 1.6 a,c,d 66.7 ± 1.2 b 67.2 ± 1.4 b
Lee-index (g/cm) 0.29 ± 0.01 0.31 ± 0.01 0.29 ± 0.02 0.29 ± 0.01
Drinking solution ingestion (ml/day) 48.3 ± 7.9 b,c,d 35.6 ± 8.6 a 30.4 ± 2.4 a 32.5 ± 2.1 a
Energy intake (kcal/day) 80.2 ± 17.4 b,c,d 68.8 ± 6.1 a 60.6 ± 7.3 a 60.4 ± 5.9 a
Feed eﬃciency (%) 5.30 ± 0.52 b,d 7.88 ± 0.61 a,c,d 5.78 ± 0.48 b 6.17 ± 0.43 a,b
NAC intake (mg/day) 0.00 c,d 0.00 c,d 0.061 ± 0.001 a,b 0.065 ± 0.002 a,b
Glycemic response (mg/dl h) 70.5 ± 1.5 b 87.1 ± 3.1 a,c,d 63.5 ± 6.5 b 60.4 ± 6.3 b
C, control rats; HS-HS, rats receiving high-sucrose diet and water; HS-N, rats receiving high-sucrose diet and water for 22 days, giving NAC in its drinking
water for more than 22 days; HS-CN, rats receiving high-sucrose diet and water for 22 days, giving NAC and control chow for more than 22 days.
Values are given as mean ± SD of the mean.
aValues signiﬁcantly diﬀerent from C group, P < .01; bValues signiﬁcantly diﬀerent from HS-HS group, P< .01; cValues signiﬁcantly diﬀerent from HS-N
group, P< .01; dValues signiﬁcantly diﬀerent from HS-CN group, P< .01.
Table 3: Serum determinations.
Serum determinations Groups
C HS-HS HS-N HS-CN
Total protein (g/dl) 6.8 ± 0.2 6.7 ± 0.3 6.6 ± 0.1 6.1 ± 1.3
TG (mmol/l) 1.89 ± 0.17 b 2.57 ± 0.19 a,c,d 1.88 ± 0.23 b 2.02 ± 0.21 b
Cholesterol (mmol/l) 2.41 ± 0.02 c 2.47 ± 0.01 c 2.00 ± 0.02 a,b,d 2.54 ± 0.09 c
HDL (mmol/l) 1.04 ± 0.02 b,c 0.68 ± 0.15 a 0.71 ± 0.08 a 1.01 ± 0.10 b,c
VLDL (mmol/l) 0.87 ± 0.05 b 1.18 ± 0.09 a,c,d 0.86 ± 0.09 b 0.93 ± 0.04 b
LDL (mmol/l) 0.49 ± 0.04 b,c,d 0.61 ± 0.11 a,c 0.43 ± 0.02 a,b,d 0.60 ± 0.10 a,c
HDL/TG 0.24 ± 0.01 b,c 0.11 ± 0.01 a,c,d 0.17 ± 0.01 a,b,d 0.22 ± 0.01 b,c
ox-LDL (mg/dl) 35.1 ± 4.6 b,c,d 56.4 ± 3.7 a,c,d 45.8 ± 4.0 a,b 42.1 ± 7.2 a,b
LH (nmol/ml) 7.5 ± 0.2 b,c 8.1 ± 0.1 a,c,d 6.7 ± 0.2 a,b,d 7.4 ± 0.1 b,c
TAS (%) 62.1 ± 5.0 b,c,d 44.8 ± 5.2 a,c,d 79.2 ± 6.1 a,b 78.9 ± 2.6 a,b
GSH (nmol/ml) 15.0 ± 0.3 15.2 ± 0.1 15.3 ± 0.6 14.8 ± 02
GSSG (nmol/ml) 0.63 ± 0.02 c,d 0.67 ± 0.02 c,d 0.57 ± 0.01 a,b 0.52 ± 0.02 a,b
GSH/GSSG 23.8 ± 0.2 b,c,d 22.7 ± 0.1 a,c,d 26.8 ± 0.1 a,b,d 28.5 ± 0.5 a,b,c
GSH-reductase (nmol/ml) 0.25 ± 0.07 b,c 0.36 ± 0.04 a,d 0.41 ± 0.05 a,d 0.22 ± 0.07 b,c
C, control rats; HS-HS, rats receiving high-sucrose diet and water; HS-N, rats receiving high-sucrose diet and water for 22 days, giving NAC in its drinking
water for more than 22 days; HS-CN, rats receiving high-sucrose diet and water for 22 days, giving NAC and control chow for more than 22 days.
Values are given as mean ± SD of the mean.
aValues signiﬁcantly diﬀerent from C group, P < .01; bValues signiﬁcantly diﬀerent from HS-HS group, P< .01; cValues signiﬁcantly diﬀerent from HS-N
group, P< .01; dValues signiﬁcantly diﬀerent from HS-CN group, P< .01.
been attributed to sucrose added to dry food, as given in this
experimental model.
The increased BMI, surface area, Lee-index and ﬁnal
body weight in HS group (Table 1), demonstrated the
eﬃciency of high-sucrose intake to induce obesity in these
animals.ConsideringfoodintakeoftheCandHS-HSgroups
(Table 2) with a 15% decrease in daily energy intake in
the later group, there was an unexpected increased weight
gain in HS-HS animals. Curiously, the food consumption
and energy intake were signiﬁcantly similar in the HS-HS,
HS-N and HS-CN groups (Table 2), while obesity was only
evidenced in HS-HS rats. This observation indicated that
dietary factors other than energy intake play important role
in body weight regulation. The eﬀect of dietary energy intakeEvidence-Based Complementary and Alternative Medicine 5
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Figure 1: Mean levels of glucose in the oral glucose tolerance test of
control rats (C) (open circle), rats receiving high-sucrose diet and
water (HS-HS) (ﬁlled square), rats receiving high-sucrose diet and
water during 22 days, giving NAC in its drinking water for more
than 22 days (HS-N) (ﬁlled triangle), rats receiving high-sucrose
diet and water during 22 days, giving NAC and control chow for
more than 22 days (HS-CN) (open diamond). (a) Values signiﬁ-
cantly diﬀerent from HS-N, HS-CN and C groups, P < .05. (b) Val-
uessigniﬁcantlydiﬀerentfromitsfastingbloodglucoselevelP<.05.
on weight gain has been questioned in recent years [24],
and energetic-restricted diets have shown poor long-term
eﬀectiveness in body weight loss [25].
Previous studies in our laboratory demonstrated that
addition of sucrose to drinking water enhanced the energy
intake in spite of the lower food consumption [11]. There-
fore, a lower energy intake from chow was compensated
by additional calories from the aqueous sucrose solutions.
Although the two experimental models induced obesity in
rats, the discrepancy in the energy intake was attributed to
the source of dietary sucrose. Results concerning weight gain
in sucrose-fed rats are not entirely conclusive, and high-
sucrose diet-induced obesity was found even in absence of
increased energy intake [26]. Note that the feed-eﬃciency
was highest in HS-HS rats indicating enhanced capacity for
energy conversion and storage. This fact indicated that one
mechanism by which the body weights were increased in
spite of reduced energy intake in HS-HS group compared
with C was the higher feed eﬃciency. NAC reduced the feed-
eﬃciency and the body weight gain (Table 2).
It was previously observed that high-sucrose diet-
induced obesity and impaired the glucose response [8]. Note
that HS-HS rats had high-glycemic response (Table 2)a n d
high-bloodglucoseaftertheOGTT,indicatingdecreasedrate
of glucose utilization and that insulin-induced inhibition of
hepatic glucose production was blunted in HS-HS rats. The
serum glucose level remaining for more time in high-levels
at the postprandial period has important role on obesity-
related hyperglycaemia.
There was a protective eﬀect of NAC, normalizing the
glucose response seen in the HS-HS compared with HS-N
group (Figure 1). It has been shown that NAC prevented
sucrose-induced insulin resistance [9, 10]. Researches in
our laboratory have demonstrated that some antioxidants
isolated from plants signiﬁcantly reduced the blood glucose
levels [2, 12]. However, in none of these studies, antioxidants
were administered in obese rats due high-sucrose diet intake.
There is a growing awareness that variation in the ratio
of starch to sucrose can aﬀect the serum levels of lipids
[12]. During periods of high-sucrose intake the hepatic
tissue can convert glucose into fatty acids, from which
triacylglycerols are made, transported to the blood steam
as VLDL and stored as fat in adipose tissue [17]. Enhanced
serum triacylglycerol, as observed in HS-HS rats (Table 3)i s
risk factor for myocardial infarction, arrhythmias and other
cardiovascular complications [27]. It is widely accepted that
HDL/TG ratio reﬂects information on LDL-composition,
its size and density, since reduced HDL/TG ratio indicates
VLDL and chylomicron remnants abnormally interaction
with HDL, changing the clearance of these lipoproteins.
Reduced HDL/TG ratio in HS-HS group (Table 3) indicated
lower size of LDL-cholesterol, and small LDL-cholesterol
is more susceptible to oxidative modiﬁcation. Ox-LDL
promotesatherosclerosisbothbyprovidinglipidssignalsthat
initially activate macrophages, and by stimulating foam cell
formation [28].
NAC had beneﬁcial eﬀects on high-sucrose diet-induced
dyslipidemia, enhancing HDL/TG ratio and reducing ox-
LDL. Cholesterol levels enhanced in HS-HS group, and NAC
reduced its level in the HS-N rats (Table 3) .T h e r ei sag r o w -
ing awareness that total serum cholesterol level is a reﬂection
of the individual lipoprotein level and metabolism [28]. HS-
N had lower VLDL than HS-HS rats (Table 3) and VLDL is
a LDL serum precursor [12]. Additionally, NAC secondary
metabolites, as occurred with S-methylcysteine sulfoxide
metabolites [29] could have properties depressing hep-
atic cholesterol synthesis. Moreover, NAC enhanced GSH-
reductase activity (Table 3) thus shifting the NADPH, a co-
factorforlipidsynthesis,toGSSGreduction.Consideringthe
importance of HDL to the reverse transport of cholesterol,
and of ox-LDL on atherosclerosis, we can aﬃrm that NAC
improved the lipid proﬁle in high-sucrose intake condition.
Judging from our experimental results, it is evident that
the NAC eﬀects on serum lipids, glucose tolerance and body
weight were at least in part, antioxidant/oxidant mediated.
First, the emerging view on the “antioxidant hypothesis” has
indicated that ROS aﬀect cellular signals [27]. ROS react
with protein thiol moieties to produce a variety of sulfur
oxidation states, thus diminishing the cellular uptake of
lipids from the blood and changing lipid constituents of
LDL, inducing LDL-oxidation. NAC reducing the oxidative
stress and serum LH improved the lipid proﬁle. Second,
hyperglycemia, even within normal no diabetic range, is
directly involved in pathogenic processes because it creates
oxidative stress. NAC decreasing the oxidative stress, as
showed by LH reduction and enhanced TAS in HS-N
rats maintained the precise glucose-intake-expenditure, thus
improving the glucose tolerance.
SeveralfactorsmayberelatedtoNACeﬀectsonoxidative
stress and decreased serum LH and ox-LDL levels. Both
enzymatic and non-enzymatic antioxidant pathways may
scavenge oxidative stress and so ox-LDL generation. During
the reduction of hydrogen peroxide, GSH is oxidized to
GSSG and the reduction of GSSG to GSH is catalyzed by
GSH-reductase. The decreased serum GSSG in HS-N group
compared to HS-HS (Table 3) indicated that NAC was used6 Evidence-Based Complementary and Alternative Medicine
to inhibit LH production, thus reducing the GSH oxidation
to GSSG, allowing increased GSH/GSSG ratio. NAC in HS-
N rats enhanced GSH-reductase activity as compared to HS-
HS,allowingtheGSHrepositionfromGSSGreduction.Note
thatTASwasenhancedinHS-Nrats.Cysteineisratelimiting
for GSH synthesis and increased dietary cysteine prevented
the high-sucrose induced decrease in hepatic GSH levels
[15]. NAC is a thiol compound with high solubility [30], this
fact can explain its action on lipid moiety of LDL, decreasing
ox-LDL.
Curiously GSH-reductase activity was also enhanced in
HS-HS group when compared to control rats. However, the
maintenance of GSH, the enhanced GSSG and decreased
GSH/GSSG ratio in HS-HS animals indicated that GSH was
not enough to inhibit the ROS action on LDL. Therefore, ox-
LDLandLHwereenhancedinHS-HSrats.InHS-CNgroup,
the ox-LDL, HDL and HDL/TG ratio normalization were
associated with the synergistic eﬀect of dietary changes and
NAC intake. Note, Table 3, that TAS and GSH/GSSG were
enhanced in these animals.
The signiﬁcance of this study has been mainly explained
by the potential application of its ﬁndings to human
nutrition and preventive medicine. Since sucrose is one of
the most important cornerstones of obesity incidence and its
adverse eﬀects, research is needed to answer an important
question: What is the best dietary supplement to improve
obesity-related eﬀects disease?
In conclusion, NAC improved the high-sucrose diet-
induced obesity and its eﬀects on glucose tolerance, lipid
proﬁle, in vivo LDL-oxidation and serum oxidative stress,
enhancingantioxidantdefences.Theapplicationofthisagent
may be feasible and beneﬁcial for high-sucrose diet-induced
obesity,whichcertainlywouldbringnewinsightsonobesity-
related adverse eﬀects control.
Funding
CNPq (Conselho Nacional de Desenvolvimento Cient´ ıﬁco e
Tecnol ´ ogico); e FAPESP (Fundac ¸˜ ao de Amparo a Pesquisa do
Estado de S˜ ao Paulo).
References
[1] M. E. Anderson, “Glutathione: an overview of biosynthesis
and modulation,” Chemico-Biological Interactions, vol. 111-
112, pp. 1–14, 1998.
[2] K. E. Campos, Y. S. Diniz, A. C. Cataneo, L. A. Faine,
M .J .Q .F .A l v e s ,a n dE .L .B .N o v e l l i ,“ H y p o g l y c a e m i c
and antioxidant eﬀects of onion, Allium cepa: dietary onion
addition, antioxidant activity and hypoglycaemic eﬀects on
diabetic rats,” International Journal of Food Sciences and
Nutrition, vol. 54, no. 3, pp. 241–246, 2003.
[3] J. Faintuch, P. B. Aguilar, and W. Nadalin, “Relevance of N-
acetylcysteine in clinical practice: fact, myth or consequence?”
Nutrition, vol. 15, no. 2, pp. 177–179, 1999.
[4] J. Pokorn´ y, “Are natural antioxidants better—and safer—than
synthetic antioxidants?” European Journal of Lipid Science and
Technology, vol. 109, no. 6, pp. 629–642, 2007.
[5] C. J. Davreux, I. Soric, A. B. Nathens et al., “N-acetyl cysteine
attenuates acute lung injury in the rat,” Shock,v o l .8 ,n o .6 ,p p .
432–438, 1997.
[6] A. Pastor, P. S. Collado, M. Almar, and J. Gonz´ alez-Gallego,
“Antioxidant enzyme status in biliary obstructed rats: eﬀects
of N-acetylcysteine,” Journal of Hepatology,v o l .2 7 ,n o .2 ,p p .
363–370, 1997.
[ 7 ]H .G u r e r ,H .O z g u n e s ,R .N e a l ,D .R .S p i t z ,a n dN .E r c a l ,
“Antioxidant eﬀects of N-acetylcysteine and succimer in red
blood cells from lead-exposed rats,” Toxicology, vol. 128, no. 3,
pp. 181–189, 1998.
[8] Y. S. Diniz, K. K. H. R. Rocha, G. A. Souza et al., “Eﬀects of N-
acetylcysteine on sucrose-rich diet-induced hyperglycaemia,
dyslipidemia and oxidative stress in rats,” European Journal of
Pharmacology, vol. 543, no. 1-3, pp. 151–157, 2006.
[9] D. Song, S. Hutchings, and C. C. Y. Pang, “Chronic N-
acetylcysteine prevents fructose-induced insulin resistance
and hypertension in rats,” European Journal of Pharmacology,
vol. 508, no. 1–3, pp. 205–210, 2005.
[10] C. Blouet, F. Mariotti, D. Azzout-Marniche et al., “Dietary
cysteine alleviates sucrose-induced oxidative stress and insulin
resistance,” Free Radical Biology and Medicine, vol. 42, no. 7,
pp. 1089–1097, 2007.
[11] Y. S. Diniz, R. M. Burneiko, F. R. F. Seiva et al., “Diet com-
pounds, glycemic index and obesity-related cardiac eﬀects,”
International Journal of Cardiology, vol. 124, no. 1, pp. 92–99,
2008.
[12] E.L.B.Novelli,NutritionandHealthyLife.OxidativeStressand
Energetic Metabolism, Tecmedd Editorial, S˜ ao Paulo, Brazil,
2005.
[13] F. Mariotti, K. L. Simbelie, L. Makarios-Lahham et al., “Acute
ingestion of dietary proteins improves post-exercise liver
glutathione in rats in a dose-dependent relationship with their
cysteinecontent,”JournalofNutrition,vol.134,no.1,pp.128–
131, 2004.
[14] S. E. Moriarty-Craige and D. P. Jones, “Extracellular thiols
and thiol/disulﬁde redox in metabolism,” Annual Review of
Nutrition, vol. 24, pp. 481–509, 2004.
[ 1 5 ]C .B l o u e t ,F .M a r i o t t i ,T .M i k o g a m i ,D .T o m e ,a n dJ . -
F. Huneau, “Meal cysteine improves postprandial glucose
control in rats fed a high-sucrose meal,” Journal of Nutritional
Biochemistry, vol. 18, no. 8, pp. 519–524, 2007.
[16] Y. S. Diniz, L. A. Faine, C. M. Galhardi et al., “Monosodium
glutamate in standard and high-ﬁber diets: metabolic syn-
drome and oxidative stress in rats,” Nutrition, vol. 21, no. 6,
pp. 749–755, 2005.
[17] E. L. B. Novelli, Y. S. Diniz, C. M. Galhardi et al., “Anthro-
pometrical parameters and markers of obesity in rats,”
Laboratory Animals, vol. 41, no. 1, pp. 111–119, 2007.
[18] A. T. Hostmark, “Variations in the glycemic response to
carbohydrates: do high responders have a special beneﬁt using
low glycemic foods?” The Open Nutrition Journal, vol. 1, pp.
1–4, 2007.
[ 1 9 ]O .H .L o w r y ,N .J .R o s e b r o u g h ,A .L .F a r r ,a n dR .J .R a n d a l l ,
“Protein measurement with the Folin phenol reagent,” The
Journal of Biological Chemistry, vol. 193, no. 1, pp. 265–275,
1951.
[20] A. E. Scoccia, M. S. Molinuevo, A. D. McCarthy, and A. M.
Cortizo,“Asimplemethodtoassesstheoxidativesusceptibility
of low density lipoproteins,” BMC Clinical Pathology, vol. 1,
article 1, pp. 1–7, 2001.Evidence-Based Complementary and Alternative Medicine 7
[ 2 1 ]Z . - Y .J i a n g ,A .C .S .W o o l l a r d ,a n dS .P .W o l ﬀ, “Lipid
hydroperoxide measurement by oxidation of Fe
2+ in the
presence of xylenol orange. Comparison with the TBA assay
and an iodometric method,” Lipids, vol. 26, no. 10, pp. 853–
856, 1991.
[22] A. C. Miller and W. F. Blakely, “Inhibition of glutathione
reductase activity by a carbamoylating nitrosourea: eﬀect of
cellular radiosensitivity,” Free Radical Biology and Medicine,
vol. 12, no. 1, pp. 53–62, 1992.
[23] F. Tietze, “Enzymic method for quantitative determination of
nanogram amounts of total and oxidized glutathione: appli-
cations to mammalian blood and other tissues,” Analytical
Biochemistry, vol. 27, no. 3, pp. 502–522, 1969.
[24] D. S. Ludwig, “Dietary glycemic index and obesity,” Journal of
Nutrition, vol. 130, no. 2, pp. 280–283, 2000.
[25] D. S. Ludwig, J. A. Majzoub, A. Al-Zahrani, G. E. Dallal,
I. Blanco, and S. B. Roberts, “High glycemic index foods,
overeating, and obesity,” Pediatrics, vol. 103, no. 3, pp. E261–
E266, 1999.
[26] A. Chicco, M. E. D’Alessandro, L. Karabatas, C. Pastorale, J.
C. Basabe, and Y. B. Lombardo, “Muscle lipid metabolism and
insulin secretion are altered in insulin-resistant rats fed a high
sucrose diet,” Journal of Nutrition, vol. 133, no. 1, pp. 127–133,
2003.
[27] J. E. Schaﬀer, “Lipotoxicity: when tissues overeat,” Current
Opinion in Lipidology, vol. 14, no. 3, pp. 281–287, 2003.
[ 2 8 ]P .B r i z z i ,G .T o n o l o ,F .C a r u s s i l l o ,M .M a l a g u a r n e r a ,M .
Maioli, and S. Musumeci, “Plasma lipid composition and LDL
oxidation,” Clinical Chemistry and Laboratory Medicine, vol.
41, no. 1, pp. 56–60, 2003.
[29] K. Kumari, B. C. Mathew, and K. T. Augusti, “Antidiabetic and
hypolipidemic eﬀects of S-methyl cysteine sulfoxide isolated
from Allium cepa Linn,” Indian Journal of Biochemistry and
Biophysics, vol. 32, no. 1, pp. 49–54, 1995.
[30] L. Bonanomi and A. Gazzaniga, “Toxicological, pharma-
cokinetic and metabolic studies on acetylcysteine,” European
Journal of Respiratory Diseases, vol. 61, no. 111, pp. 45–51,
1980.